Profil
Wilhelm Horn co-founded Accovion GmbH in 2002 and currently serves as Chief Executive Officer.
Prior to joining Accovion, he was Head of Clinical Development and a Global Project Leader for Aventis (formerly known as Hoechst AG) and a Medical Director of Cassella-Riedel.
Previously, Dr. Horn worked with the Harvard Medical School.
Ehemalige bekannte Positionen von Wilhelm Horn
Unternehmen | Position | Ende |
---|---|---|
Accovion GmbH
Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Accovion GmbH operates as a contract research organization, which offers planning and conducting of clinical drug tests, data collection, and processing. It also provides services in the areas of design, analysis, and creation of statistical and clinical reports. The firm also specializes in biometrical planning and evaluation, pharmaco-economic studies, as well as quality control and assurance. The company was founded on May 22, 2001 and is headquartered in Eschborn, Germany. | Präsident | 01.07.2009 |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Aventis Pharma AG | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Accovion GmbH
Accovion GmbH Miscellaneous Commercial ServicesCommercial Services Accovion GmbH operates as a contract research organization, which offers planning and conducting of clinical drug tests, data collection, and processing. It also provides services in the areas of design, analysis, and creation of statistical and clinical reports. The firm also specializes in biometrical planning and evaluation, pharmaco-economic studies, as well as quality control and assurance. The company was founded on May 22, 2001 and is headquartered in Eschborn, Germany. | Commercial Services |
Aventis Pharma AG |